Statistical Excellence in the Pharmaceutical Industry Award

We are now accepting entries for the 2020 Award

Our award for statistical excellence in the pharmaceutical industry is made jointly with the RSS (Royal Statistical Society) every year. The award is for the most influential example of the application of an existing statistical practice, or the implementation of an innovative statistical practice, in this industry.

Criteria

We are looking for entries that have demonstrated one or more of the following:

  • A clear understanding of the needs of researchers and investigators
  • An application of an existing statistical practice to a new area that has increased the quality and efficiency of investigations
  • A new development in the design of investigations and/or the analysis of data that has led to further insights into the safety, efficacy and value of medicines or devices
  • An excellent way to communicate results that is clear and helpful to a wide array of users, showing how statisticians understand the range of user needs

Nominees can be based anywhere in the world and do not need to be a member of PSI or the RSS. Updates on where and when the Award will be presented will be posted in due course.

Download the entry form here.

The deadline for entries is midnight on Friday 22nd May 2020.

Previous Winners

The 2019 award was jointly presented to Mike Smith (Pfizer) for his work on ‘Excellence in research around population modelling in drug development’ and its ‘pioneering practical Bayesian methods with drug development in the context of optimising decision making within trials and modelling dose response with pharmacokinetic/pharmacodynamic modelling’ and Graeme Archer and Jacquie Christie (GSK) for their work on ‘Quantitative Decision-Making for clinical development’, which was deemed to be ‘at the cutting edge of revolutionising data driven decision making within the industry’. 

The 2018 award was jointly presented to Dr. Mouna Akacha (Novartis) for “Enhancing drug development using clinically interpretable treatment effect measures (‘estimands‘) that allow for efficient statistical analyses” and Dr. Simon Bate for “Improving the quality and reliability of animal research through the use of InVivoStat: a statistical software package for animal researchers”. 

The 2017 award was presented to Michael O'Kelly for his work 'Promoting analytical solutions and best practices for handling missing data in pharmaceutical industry'.  The judges felt that in this respect, he has made a major contribution to enhancing the practical application of modelling and simulation methodology and tools for analysing data with missing values. 
Richard Nixon of Novartis was presented with the award in 2016 for “Enhancing decision-making in drug development using quantitative approaches’. 

Katrina Gore and Nicky Best (joint winners, 2015, Pfizer and GSK respectively). Katrina Gore for her work on the Assay Capability Tool (ACT), designed to guide the development of drug discovery assays. Nicky Best for her work implementing a process that has turned beliefs about the chances of success into formal prior distributions.

Award cropped

Upcoming Events

Introduction To Industry Training Course 2020

The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 sessions in the UK. The start of the 2020-2021 course will be delayed until face-to-face meetings with up to 30 people are permitted and companies are allowing travel again.

PSI Webinar: Patient preference studies

In this webinar you will hear an introduction to what a patient preference study is as well as an overview of where this type of study can inform regulatory decision making. This will be followed by 2 examples looking at potential approaches to eliciting patient preference.

PSI Vaccine SIG Webinar: Statistical Topics on COVID-19 Therapeutic and Vaccine Clinical Trials

We are delighted to be joined by Frank Harrell who will present 'Sequential Bayesian Designs for Rapid Learning in COVID-19 Therapeutic Trials'; and also by Dean Follmann, who will present on 'Statistical Aspects of COVID-19 Vaccine Trials'. Join us for this insightful and highly topical webinar.

Joint PSI, EFSPI & ASA BIOP Webinar: Estimands

PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.

Latest Jobs

Senior Research Statistician

As a member of the Statistical Sciences and Modeling (SSM) group, provide statistical technical support to projects on complex problems and methods.

Statisticians - Oncology

Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.

Therapeutic Area Global Expert Statistician - CNS & Retinopathies

You are looking for a new professional challenge - we offer you this interesting position in a global company that has been awarded several times the status of best employer.